Entera Bio annual capital expenditures (capex)
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Entera Bio Capital Expenditures (CapEx) Growth & History (ENTX)
Entera Bio's capital expenditures (capex) was $107,000 for fiscal 2025.
View full Entera Bio company overviewEntera Bio annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $107,000 | $104,000 | +3466.67% |
| 2024 | 2024-12-31 | $3,000 | −$14,000 | −82.35% |
| 2023 | 2023-12-31 | $17,000 | −$30,000 | −63.83% |
| 2022 | 2022-12-31 | $47,000 | $30,000 | +176.47% |
| 2021 | 2021-12-31 | $17,000 | −$36,000 | −67.92% |
| 2020 | 2020-12-31 | $53,000 | $13,000 | +32.50% |
| 2019 | 2019-12-31 | $40,000 | −$28,000 | −41.18% |
| 2018 | 2018-12-31 | $68,000 | $17,000 | +33.33% |
| 2017 | 2017-12-31 | $51,000 | $10,000 | +24.39% |
| 2016 | 2016-12-31 | $41,000 | — | — |
Entera Bio quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3,000 | −$26,000 | −89.66% |
| Q1 2026 | 2026-03-31 | $0 | −$8,000 | — |
| Q4 2025 | 2025-12-31 | $27,000 | $24,000 | +800.00% |
| Q3 2025 | 2025-09-30 | $43,000 | $43,000 | — |
| Q2 2025 | 2025-06-30 | $29,000 | $29,000 | — |
| Q1 2025 | 2025-03-31 | $8,000 | $8,000 | — |
| Q4 2024 | 2024-12-31 | $3,000 | −$2,000 | −40.00% |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q2 2024 | 2024-06-30 | $0 | −$1,000 | — |
| Q1 2024 | 2024-03-31 | $0 | −$11,000 | — |
| Q4 2023 | 2023-12-31 | $5,000 | $2,000 | +66.67% |
| Q3 2023 | 2023-09-30 | $0 | −$2,000 | — |
| Q2 2023 | 2023-06-30 | $1,000 | −$18,000 | −94.74% |
| Q1 2023 | 2023-03-31 | $11,000 | −$12,000 | −52.17% |
| Q4 2022 | 2022-12-31 | $3,000 | −$7,000 | −70.00% |
| Q3 2022 | 2022-09-30 | $2,000 | −$5,000 | −71.43% |
| Q2 2022 | 2022-06-30 | $19,000 | $19,000 | — |
| Q1 2022 | 2022-03-31 | $23,000 | $23,000 | — |
| Q4 2021 | 2021-12-31 | $10,000 | — | — |
| Q3 2021 | 2021-09-30 | $7,000 | — | — |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $0 | — | — |
Entera Bio capital expenditures (capex) trends
Over the last five fiscal years, Entera Bio's capital expenditures (capex) increased from $53,000 to $107,000, a change of $54,000. The latest reported quarter, Q2 2026, shows $3,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio source filings ↗